000 04191nam a22004695i 4500
001 u372263
003 SIRSI
005 20160812084050.0
007 cr nn 008mamaa
008 110728s2011 xxu| s |||| 0|eng d
020 _a9781441996312
_9978-1-4419-9631-2
040 _cMX-MeUAM
050 4 _aRM1-950
082 0 4 _a615
_223
100 1 _aNickerson, Beverly.
_eeditor.
245 1 0 _aSample Preparation of Pharmaceutical Dosage Forms
_h[recurso electrónico] :
_bChallenges and Strategies for Sample Preparation and Extraction /
_cedited by Beverly Nickerson.
264 1 _aBoston, MA :
_bSpringer US,
_c2011.
300 _aXIV, 397p. 88 illus., 31 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aProperties that Impact Sample Preparation and Extraction of Pharmaceutical Dosage Forms -- Sampling Considerations -- Agitation and Particle Size Reduction Techniques -- Liquid-Liquid and Solid-Phase Extraction Techniques -- Extraction Techniques Leveraging Elevated Temperature and Pressure -- Addressing Drug-Excipient Interactions -- Sample Preparation for Solid Oral Dosage Forms -- Sample Preparation for Select Non Solid Dosage Forms -- Post-Extraction Considerations -- Sample Preparation Method Validation -- Application of Quality by Design (QbD)  Principles for Sample Preparation -- Automation and Sample Preparation -- A Systematic Approach for Investigating Aberrant Potency Values -- Green Chemistry Considerations for Sample Preparation -- No Sample Preparation.
520 _aDesigned as a resource guide for analytical scientists working in the pharmaceutical industry, this comprehensive guide is focused entirely on sample preparation and extraction of pharmaceutical dosage forms.    This book is divided into four parts: •          Part One covers dosage form and diluent properties that impact sample preparation of pharmaceutical dosage forms and the importance of sampling considerations in generating data representative of the drug product batch.  • ??        Part Two reviews specific sample preparation techniques typically used with pharmaceutical dosage forms. •          Part Three discusses sample preparation method development for different types of dosage forms including addressing drug excipient interactions and post extraction considerations, as well as method validation and applying Quality by Design (QbD) principles to sample preparation methods.   •          Part Four examines additional topics in sample preparation including automation, investigating aberrant potency results, green chemistry considerations for sample preparation and the ideal case where no sample preparation is required for sample analysis.   Analytical scientists in the pharmaceutical industry as well as in analytical testing laboratories will find this book a valuable resource in developing and troubleshooting sample preparation methods for drug products at all stages in the lifecycle of a drug product. Beverly Nickerson, Ph.D., is Associate Research Fellow in Analytical Development in Pfizer Global Research and Development, Pfizer Inc.  Dr. Nickerson is well published in peer-reviewed journals, is author of several book chapters and has presented at various scientific meetings.  She has extensive experience in early stage and late stage drug development.
650 0 _aMedicine.
650 0 _aToxicology.
650 0 _aPharmaceutical technology.
650 0 _aPharmacy.
650 0 _aBiochemistry.
650 1 4 _aBiomedicine.
650 2 4 _aPharmacology/Toxicology.
650 2 4 _aPharmaceutical Sciences/Technology.
650 2 4 _aBiochemistry, general.
650 2 4 _aPharmacy.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781441996305
856 4 0 _zLibro electrónico
_uhttp://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-1-4419-9631-2
596 _a19
942 _cLIBRO_ELEC
999 _c200143
_d200143